Lung cancer is among the common types of cancer that affect many individuals and are associated with increased mortality rates due to rapid progression of the disease. Even though the situation with lung cancer is improving as new treatments are found, lung cancer is still a problem for the healthcare workers with little increase in survival rates. However, the pharmaceutical industry is revolutionizing lung cancer treatment through the development of personalized medicine, offering new hope for patients and healthcare providers alike.
Personalized medicine means that medical procedures are adjusted depending on a patient’s genetic profile, medical history, and personal habits. This approach has immensely impacted the diagnosis and treatment of patients with lung cancer as healthcare professionals are able to determine the most suitable course of action.
